2005
DOI: 10.2337/diacare.28.2.461
|View full text |Cite
|
Sign up to set email alerts
|

Proteases and the Diabetic Foot Syndrome: Mechanisms and Therapeutic Implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
111
0
9

Year Published

2005
2005
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 173 publications
(124 citation statements)
references
References 122 publications
1
111
0
9
Order By: Relevance
“…By contrast, the inflammatory reaction in diabetic lesions with poor cicatrization appears to slow recovery by generating an intense proteolytic response, which is mediated by elastase and neutrophils, TNF and IL-1. This inflammatory reaction results from bacterial contamination and recurrent trauma in tissues; however, is not associated with pain (15,18,26,44).…”
Section: Discussionmentioning
confidence: 99%
“…By contrast, the inflammatory reaction in diabetic lesions with poor cicatrization appears to slow recovery by generating an intense proteolytic response, which is mediated by elastase and neutrophils, TNF and IL-1. This inflammatory reaction results from bacterial contamination and recurrent trauma in tissues; however, is not associated with pain (15,18,26,44).…”
Section: Discussionmentioning
confidence: 99%
“…Many researchers have indicated that a retarded remodeling process is caused by abnormally elevated levels of a matrix metalloproteinase (MMP), a superfamily of proteases that can degrade various kinds of extracellular matrix. [2][3][4] In nondiabetic wounds, MMPs are important for remodeling defective tissues by increasing the migration of fibroblasts and endothelial cells of the connective tissues. Their expression levels are tightly…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, when s f 50.002 the influx of inflammation to the wound site did not elicit more damage than the initial level of D50.5. These experiments correlate to the use of agents such as recombinant platelet-derived growth factor 37 and basic fibroblast growth factor (bFGF). 38 The Akita et al 38 study reported a 20% decrease in healing time with the use of bFGF, which is on the same order of magnitude as the decrease seen in our model experiment.…”
Section: Resultsmentioning
confidence: 99%
“…Impaired fibroblast production results in a nonhealing state, but under conditions where the production is increased we have wounds that heal at notably faster rates. 37,38 This provides a framework from which to test a new hypothesis in a living model.…”
Section: Discussionmentioning
confidence: 99%